US Patent Issued to Sana Biotechnology on July 7 for "CD8-specific antibody constructs and compositions thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,180, issued on July 7, was assigned to Sana Biotechnology Inc. (Seattle).

"CD8-specific antibody constructs and compositions thereof" was invented by Patricia Ann Cruite (Medford, Mass.), Shirisha Amatya (Cambridge, Mass.), Hugh Harding (Framingham, Mass.) and Lauren Pepper MacKenzie (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are antibodies or antigen binding fragments thereof that specifically bind human CD8. Also disclosed are fusion proteins comprising a Henipavirus glycoprotein G and CD8 antibodies for targeting and transducing cells expressing CD8. Viral vectors and other compositions containing the fusion pr...